Onxeo SA Appoints Bryan Giraudo as Independent Member of its Board of Directors Replacing Thomas Hofstaetter
November 23, 2021 at 01:00 pm EST
Onxeo SA announced the appointment of Bryan Giraudo as independent member of the Board of Directors, replacing Thomas Hofstaetter after three mandates. Bryan Giraudo is both the Chief Operating Officer & Chief Financial Officer of Gossamer Bio. Previously, he served as Senior Managing Director at LEERINK Partners, where he was responsible for LEERINK?s Western North America and Asia life sciences investment banking practice.